Biomab EGFR 50mg Injection consists of the active Nimotuzumab. It is a monoclonal antibody used in cancer treatment. It has been approved for the treatment of head and neck cancer, as well as for certain types of brain cancer. This medication is typically used with other cancer treatments, such as chemotherapy and radiation therapy. The drug effectively improves overall survival and disease-free survival in some cancer patients. However, like all cancer treatments, it can have side effects, including allergic reactions, skin rashes, and flu-like symptoms, and transplant.

There are no absolute contraindications to Biomab EGFR 50mg Injection, but there are some precautions and potential contraindications to consider. For example, patients with a history of severe allergic reactions or hypersensitivity to it or its components should not receive the medication. Additionally, patients with certain medical conditions, such as severe liver or kidney disease, may need to be monitored closely or have their dosages adjusted.

• Head and neck cancer
• Certain types of brain cancer
• Esophageal cancer

The therapeutic effect of Biomab EGFR 50mg Injection is primarily focused on its ability to target and bind to the epidermal growth factor receptor (EGFR) found on many cancer cells. Doing so can block the growth and spread of cancer cells, ultimately leading to improved patient outcomes. One of the advantages is its targeted therapy approach, which allows it to target cancer cells while minimizing damage to healthy cells specifically. This can help to reduce side effects and improve the overall quality of life for cancer patients undergoing treatment.

Biomab EGFR 50mg Injection is an injectable medication that a healthcare professional administers. It is typically given as an intravenous injection. The dose and frequency will depend on the type of cancer being treated, the patient's overall health, and other medications the patient may be taking. If you miss a dose, contact your healthcare provider as soon as possible. Your healthcare provider may recommend rescheduling your next dose or adjusting your dosing schedule. Do not double the dose to make a missed dose.

Serious:

Allergic reactions

Difficulty breathing

Swelling of the face or throat, or hives

Infusion reactions (fever, chills, or low blood pressure)

Chest pain

Irregular heartbeat

Lung problems (cough or shortness of breath)

Liver problems (jaundice or abdominal pain)

Common: 

Skin rash

Diarrhea

Nausea and vomiting

Fatigue

Headache

Fever

Pain at the injection site

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Biomab EGFR 50mg Injection and reduce effectiveness by causing undesirable side effects.

• Biomab EGFR 50mg Injection should be stored in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F).
• It does not need to be frozen, as this can damage its efficacy.
• Once a vial is opened, it should be used immediately.
• If the drug is not used immediately, it can be stored at room temperature for 4 hours. After 4 hours, any remaining drug should be discarded.
• Keep out of reach of children and pets.

It is important to carefully read the medication label before taking Biomab EGFR 50mg Injection. Follow the instructions provided by your healthcare provider and the label, such as how much to take and how often. Your healthcare provider can provide more information on the risks and benefits of it and can help you determine if it is the right treatment option for you. It is important to report any side effect you may experience during treatment to your healthcare provider. Pregnancy and breastfeeding are not recommended while taking this medication. Before starting it or any other medication, inform your healthcare provider of any allergies or medications you are taking. This can help prevent any potential interactions or adverse effects.